Press Releases
Early diagnosis of bowel cancer in the England...
The importance of national screening Data published by Cancer Research UK and Public Health England’s National Cancer Intelligence Network have reported, for the first time...
Press Releases
Updated Label for Daklinza (daclatasvir) for the 12-week Treatment...
European Commission has approved an updated label for Daklinza for the treatment of genotype 3 chronic hepatitis C (HCV). The update allows the use of...
Press Releases
Follow-up Data from Two Pivotal Opdivo (nivolumab) Trials Demonstrates...
European Commission has approved an updated label for Daklinza for the treatment of genotype 3 chronic hepatitis C (HCV). The update allows the use of...
Press Releases
ALLY-1 Trial Results Show Investigational Daclatasvir-Based Regimen Cures 94%...
The primary endpoints were successfully met in ALLY-1, a Phase III clinical trial evaluating a 12-week regimen of daclatasvir and sofosbuvir once-daily with ribavirin for...
Press Releases
U.S. Food and Drug Administration Accepts Supplemental Biologics License...
Submission based on positive results of the landmark, global Phase 3 study, CheckMate -057 evaluating overall survival versus standard of care in non-squamous non-small cell...
Press Releases
Bristol-Myers Squibb to Host Investor Teleconference to Discuss World...
Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference on Tuesday, September 8 at 8 a.m. EDT (6 a.m. MDT) to review data presented at the...
Press Releases
coramaze technologies raises EUR 4.5 million to advance novel...
Coramaze technologies GmbH, a German medical device company, is developing themitramaze® valve repair system – a novel concept for transcatheter mitral valve repair (TMVRep) intended...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.